Citations 79

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

Neurology | July 25, 2015 | Volume: 85 | Issue: 8 | Pages: 722-729

10.1212/wnl.0000000000001856 | PMID 26208962

Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology

Neurology Clinical Practice | June 8, 2015 | Volume: 5 | Issue: 3 | Pages: 216-223

10.1212/cpj.0000000000000133 | PMID 29443212

Relapses and disability accumulation in progressive multiple sclerosis

Neurology | November 15, 2014 | Volume: 84 | Issue: 1 | Pages: 81-88

10.1212/wnl.0000000000001094 | PMID 25398229

Dementia in MS complicated by coexistent Alzheimer disease

Neurology Clinical Practice | June 9, 2014 | Volume: 4 | Issue: 3 | Pages: 226-230

10.1212/cpj.0000000000000030 | PMID 25110620

Specific pattern of gadolinium enhancement in spondylotic myelopathy

Annals of Neurology | May 16, 2014 | Volume: 76 | Issue: 1 | Pages: 54-65

10.1002/ana.24184 | PMID 24838831

Objective To highlight a specific under‐recognized radiological feature of spondylotic myelopathy often resulting in misdiagnosis. Methods Patients evaluated between January 1, 1996 and December 31, 2012 who met the following criteria were included: (1) spondylotic myelopathy was suspected, (2) gadolinium enhancement was detected, and (3) spinal surgery was performed. Results Fifty‐six patients (70% men) whose median age was 53.5 years (range = 24–80) were included. Spinal cord magnetic resonance imaging (cervical in 52; thoracic in 4) revealed longitudinal spindle‐shaped T2‐signal hyperintensity (100%) and cord enlargement (79%) accompanied by a characteristic pancakelike transverse band of gadolinium enhancement in 41 (73%), typically immediately caudal to the site of maximal spinal stenosis. Forty (71%) patients were initially diagnosed with neoplastic or inflammatory myelopathies, and decompressive surgery was delayed by a median of 11 months (range = 1–64). Spinal cord biopsy in 6 did not reveal any alternative diagnosis. Ninety‐five percent were stable or improved. Gadolinium enhancement persisted in 75% at 12 months, raising concern about the accuracy of the initial diagnosis. Twenty patients required a gait aid (36%) at last follow‐up (median = 60 months, range = 10–172). The need for a gait aid preoperatively ( p = 0.005), but not delay of surgery, predicted the need for gait aid at final follow‐up. Interpretation Transverse pancakelike gadolinium enhancement associated with and just caudal to the site of maximal stenosis and at the rostrocaudal midpoint of a spindle‐shaped T2 hyperintensity suggests that spondylosis is the cause of the myelopathy. Persistent enhancement for months to years following decompressive surgery is common. Recognition is important to prevent inappropriate interventions or delay in consideration of a potentially beneficial decompressive surgery. Ann Neurol 2014;76:54–65
Amyloid–β-related angiitis presenting as a uveomeningeal syndrome

Neurology | October 18, 2013 | Volume: 81 | Issue: 20 | Pages: 1796-1798

10.1212/01.wnl.0000435560.00234.a7 | PMID 24132378

Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder

Neurology Clinical Practice | October 14, 2013 | Volume: 3 | Issue: 5 | Pages: 448-451

10.1212/cpj.0b013e3182a78f82 | PMID 29473607

Therapeutic Decision Making in a New Drug Era in Multiple Sclerosis

Seminars in Neurology | May 25, 2013 | Volume: 33 | Issue: 01 | Pages: 005-012

10.1055/s-0033-1345709 | PMID 23709208

Current and Emerging Therapies for Multiple Sclerosis

Seminars in Neurology | May 25, 2013 | Volume: 33 | Issue: 01 | Pages: 003-004

10.1055/s-0033-1345711 | PMID 23709207

Sjögren's syndrome with trigeminal neuropathy: motor involvement

Practical Neurology | May 24, 2013 | Volume: 13 | Issue: 5 | Pages: 340-342

10.1136/practneurol-2013-000560 | PMID 23703941